Disclosures
The Association of the British Pharmaceutical Industry (ABPI) Code of Practice requires all companies to document and publicly disclose certain transfers of value (ToVs) made directly or indirectly to healthcare professionals (HCPs), other relevant decision makers (ORDMs) and healthcare organisations (HCOs) located in Europe, as well as to research & development (R&D) projects and patient organisations.
Working with HCPs/ORDMs and HCOs
Merz is committed to compliance and working within the ABPI Code of Practice and applicable laws. For payments made to HCPs/ORDMs and HCOs, including R&D projects in the last three years (2016, 2017 and 2018), please refer to the ABPI Disclosure Database:
Working with patient groups
Merz have also made the following contributions to working with patient groups in 2016, 2017 and 2018:
Contributions to Patient Organisations in 2016
Organisation
Amount
Description
The Stroke Association
£3607.00
Contribution to cost of event
Contributions to Patient Organisations in 2017
Organisation
Amount
Description
The Stroke Association
£4000
Contribution towards the cost of producing stroke guides for patients
Action for Dystonia, Diagnosis, Education and Research (ADDER)
£760
Funding support for patient leaflets
Chest Heart & Stroke Scotland
£500
Contribution towards the cost of a meeting.
UK National Intrathecal Baclofen Trust
£500
Contribution towards the cost of a meeting
Contributions to Patient Organisations in 2018
Organisation
Amount
Description
The Dystonia Society
£500
Contribution towards the cost of a meeting.
The Stroke Association
£4180
Contribution towards the cost of the UK Stroke Forum Conference 2018. In return Merz UK received stand space at the event.
The Stroke Association
£1250
Contribution towards the cost of the Northern Ireland Stroke Conference 2018. In return Merz UK received stand space at the event.
